Department of Biosciences, Biotechnology and Pharmacological Sciences, University of Bari, 70125 Bari, Italy.
Biochem J. 2012 Apr 1;443(1):241-7. doi: 10.1042/BJ20111420.
The essential cofactors CoA, FAD and NAD+ are synthesized outside the peroxisomes and therefore must be transported into the peroxisomal matrix where they are required for important processes. In the present study we have functionally identified and characterized SLC25A17 (solute carrier family 25 member 17), which is the only member of the mitochondrial carrier family that has previously been shown to be localized in the peroxisomal membrane. Recombinant and purified SLC25A17 was reconstituted into liposomes. Its transport properties and kinetic parameters demonstrate that SLC25A17 is a transporter of CoA, FAD, FMN and AMP, and to a lesser extent of NAD+, PAP (adenosine 3',5'-diphosphate) and ADP. SLC25A17 functioned almost exclusively by a counter-exchange mechanism, was saturable and was inhibited by pyridoxal 5'-phosphate and other mitochondrial carrier inhibitors. It was expressed to various degrees in all of the human tissues examined. Its main function is probably to transport free CoA, FAD and NAD+ into peroxisomes in exchange for intraperoxisomally generated PAP, FMN and AMP. The present paper is the first report describing the identification and characterization of a transporter for multiple free cofactors in peroxisomes.
必需的辅酶 CoA、FAD 和 NAD+ 在过氧化物酶体外合成,因此必须被转运到过氧化物酶体基质中,在那里它们是重要过程所必需的。在本研究中,我们功能鉴定并表征了 SLC25A17(溶质载体家族 25 成员 17),它是唯一先前被证明定位于过氧化物酶体膜的线粒体载体家族成员。重组和纯化的 SLC25A17 被重构成脂质体。其转运特性和动力学参数表明,SLC25A17 是 CoA、FAD、FMN 和 AMP 的转运体,并且在较小程度上是 NAD+、PAP(腺苷 3',5'-二磷酸)和 ADP 的转运体。SLC25A17 几乎完全通过反向交换机制发挥作用,是饱和的,并被吡哆醛 5'-磷酸和其他线粒体载体抑制剂抑制。它在所有检查的人类组织中都以不同程度表达。其主要功能可能是将游离的 CoA、FAD 和 NAD+ 转运到过氧化物酶体中,以换取过氧化物酶体内产生的 PAP、FMN 和 AMP。本文是第一篇描述过氧化物酶体中多种游离辅酶转运体的鉴定和表征的论文。